Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2003
08/27/2003CN1438216A Method for increasing citrulline and hyperplasia-resisting factor active matter content in pumpkin seeds and method for extracting same
08/27/2003CN1438003A Gel pill containg pine-nut oil and Radix oenotherae Erythrosepalae oil
08/27/2003CN1437995A Yidaokang (for insulin) powder and preparation method
08/27/2003CN1437962A Sugar-reducing health-care food
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
08/27/2003CN1119291C Method of production of medical electrolysed water and dialysis apparatus using water asdialysis liquid
08/27/2003CN1119166C Health beverage for preventing and curing hypertension and hyperlipemia
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610890 Treatment and/or prevention of diabetic complications; such as 3,3',4,4',5,5'-hexabromo-2,2'-dihydroxy-oxydiphenyl
08/26/2003US6610852 Prevent tissue damage; antidiabetic agents; Alzheimer's disease
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610746 Treating non-insulin dependent diabetes mellitus, insulin resistance, Syndrome X, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, polycystic ovary syndrome, cataracts and hyperglycemia; kits
08/26/2003US6610744 Methods of treatment with compounds having RARα receptor specific or selective activity
08/26/2003US6610721 Imidazo heterocyclic compounds
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610703 Administering long-chain N-alkyl derivative of deoxynojirimycin having from nine to about twenty carbon atoms in alkyl chain
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610698 Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610696 Such as 2-(4-(2-(2-(4-(3,5-dimethyl-isoxazol-4-yl)-phenyl)-5-methyloxazol-4-yl) -ethyoxy)-phenoxy)-2-methylpropionic acid for treatment of diabetes (lowering serum triglycerides)
08/26/2003US6610695 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease
08/26/2003US6610690 Administering optically pure (S,S) enantiomer of reboxetine
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610685 Fused indole derivatives
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610681 Neurotherapeutic clavulanate composition and method
08/26/2003US6610649 To stimulate Na+K+ATPase activity which has been shown to be reduced in patients with insulin-dependent diabetes mellitus to treat or prevent diabetic neuropathy, nephropathy and retinopathy
08/26/2003US6610325 Pharmaceutical medicine comprises an iron salt, not less than two polyols, a binding agent, a lubricating agent, and a flavoring agent. The dose of elemental iron is not less than 5 mg, and preferably 10 mg to 15 mg per tablet. The polyols are
08/26/2003US6610320 Mixture of cocoa plant extract and antichloesterol agent
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610283 Poly(diallylamine)-based bile acid sequestrants
08/26/2003US6610272 Medicinal aerosol formulation comprising pioglitazone hydrochloride and a protective colloid amino acid stabilizer
08/26/2003CA2092211C Imidazole compounds, their preparation and use
08/23/2003CA2473075A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
08/21/2003WO2003069302A2 Alpha-substituted arylalkyl phosphonate derivatives
08/21/2003WO2003068959A1 Novel screening method
08/21/2003WO2003068937A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
08/21/2003WO2003068818A1 Novel glutamate receptor and utilization thereof
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068776A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
08/21/2003WO2003068773A1 Pyrazolopyridine derivatives
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068757A1 Novel pyridin- and pyrimidin-derivatives
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068751A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders
08/21/2003WO2003068748A1 Novel pyridine- and quinoline-derivatives
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068740A1 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
08/21/2003WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068267A1 Composition for oral or rectal administration
08/21/2003WO2003068253A1 Methods and compositions for the treatment of eye diseases
08/21/2003WO2003068241A1 Percutaneous preparations
08/21/2003WO2003068240A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068231A2 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068225A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn$g(g)
08/21/2003WO2003068218A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/21/2003WO2003068215A1 Drugs for mitochondrial diseases
08/21/2003WO2003068210A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
08/21/2003WO2003068205A1 Compositions and foods for improving lipid metabolism
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068199A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003068195A1 Oral dosage form for controlled drug release
08/21/2003WO2003068191A1 Formulations of atorvastatin stabilized with alkali metal additions
08/21/2003WO2003068166A2 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068140A2 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003WO2003068008A1 Water-dispersible coenzyme q10 dry powders
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003027075A3 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
08/21/2003WO2003024474A3 Anti-inflammatory agent
08/21/2003WO2003020217A3 Novel pyrazole analogs acting on cannabinoid receptors
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003US20030159164 Animal feeds
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158399 Compositions and methods for the treatment and diagnosis of immune disorders
08/21/2003US20030158381 Novel insulin/igf/relaxin family polypeptides and dnas thereof
08/21/2003US20030158241 Used for treatment of diabetes and a complication thereof, hyperlipidemia and a complication thereof, hyperuricemia, leukemia, and pancreatitis.
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158235 Pyridine amido derivatives
08/21/2003US20030158225 Novel compounds
1 ... 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 ... 1298